Related Experiment Videos
In-vitro activity of roxithromycin against Chlamydia trachomatis
A Moroni1, V Sambri, F Rumpianesi
1Institute of Microbiology, University of Bologna, Italy.
Journal of Chemotherapy (Florence, Italy)
|January 1, 1991
Abstract:
Ten Chlamydia trachomatis isolates were tested for their sensitivity to roxithromycin, in comparison with erythromycin and tetracycline. The minimum inhibitory and minimum bactericidal concentrations of roxithromycin ranged from 0.03-0.12 and 0.25-1 microg/ml, respectively.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The pivotal role of pro-anabolic modulators on muscle mass and function: a systematic review.
Nutrition research reviews·2026
Imaging in osteogenesis imperfecta: Where we are and where we are going.
European journal of medical genetics·2024
Bioelectrical Impedance Vector Analysis (BIVA) for the monitoring of body composition in pregnancy.
European journal of clinical nutrition·2021
Six-month progression-free survival-related tumor growth rate after upfront chemotherapy as an outcome measure and potential prognostic or stratification variable for patients with unresectable pancreatic adenocarcinoma: an exploratory study cohorts analysis.
Journal of chemotherapy (Florence, Italy)·2026
Pharmacogenomic biomarkers in oncology: evidence, clinical utility, and barriers to implementation.
Journal of chemotherapy (Florence, Italy)·2026
Efficacy and safety of TROP2 antibody-drug conjugate-containing regimen in the patients with HER2 negative metastatic breast cancer and advanced non-small-cell lung cancer.
Journal of chemotherapy (Florence, Italy)·2026
Efficacy and safety of PD-1/PD-L1 inhibitor-combined chemotherapy versus chemotherapy alone in extensive-stage small-cell lung cancer: a meta-analysis.
Journal of chemotherapy (Florence, Italy)·2026
A 1:1:1 propensity score matching design to account for center-specific antimicrobial treatment or prophylaxis in observational studies: the case of the POSACOVID study.
Journal of chemotherapy (Florence, Italy)·2026
Emerging bacterial membrane vesicles from microbial messengers to therapeutic nanocarriers.
Journal of controlled release : official journal of the Controlled Release Society·2026
Characterization and depolymerase activity analysis of Acinetobacter baumannii bacteriophage vB_AbaP_IME546.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2026
Antimicrobial Peptide BSN-37 Enhances Macrophage Immune Activation Through the circBptf-Rbm14-Mediated Regulatory Axis.
Probiotics and antimicrobial proteins·2026